• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠-肝轴:宿主微生物群相互作用塑造肝癌发生。

The gut-liver axis: host microbiota interactions shape hepatocarcinogenesis.

机构信息

Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA; Centre de Recherche du CHU de Québec - Université Laval, Axe Oncologie, Québec, QC G1V 4G2, Canada; Centre de Recherche sur le Cancer de l'Université Laval, Québec, QC G1R 3S3, Canada.

Centre de Recherche du CHU de Québec - Université Laval, Axe Oncologie, Québec, QC G1V 4G2, Canada; Centre de Recherche sur le Cancer de l'Université Laval, Québec, QC G1R 3S3, Canada; Centre de Recherche en Données Massives de l'Université Laval, Québec, QC G1V 0A6, Canada; Département de Biologie Moléculaire, Biochimie Médicale et Pathologie, Faculté de Médecine, Université Laval, Québec, QC G1V 0A6, Canada.

出版信息

Trends Cancer. 2022 Jul;8(7):583-597. doi: 10.1016/j.trecan.2022.02.009. Epub 2022 Mar 21.

DOI:10.1016/j.trecan.2022.02.009
PMID:35331674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9232941/
Abstract

Although their etiologies vary, tumors share a common trait: the control of an oncogenic transcriptional program that is regulated by the interaction of the malignant cells with the stromal and immune cells in the tumor microenvironment (TME). The TME shows high phenotypic and functional heterogeneity that may be modulated by interactions with commensal microbes (the microbiota) both systemically and locally. Unlike host cells, the microbiota adapts after environmental perturbations, impacting host-microbe interactions. In the liver, the bidirectional relationship in the gut and its associated microbiota creates an interdependent environment. Therefore, the gut microbiota and its metabolites modulate liver gene expression directly and indirectly, causing an imbalance in the gut-liver axis, which may result in disease, including carcinogenesis.

摘要

虽然肿瘤的病因各异,但它们有一个共同的特征:致癌转录程序的失控,而该程序受到恶性细胞与肿瘤微环境(TME)中的基质细胞和免疫细胞相互作用的调控。TME 表现出高度的表型和功能异质性,这种异质性可能受到与共生微生物(微生物组)的系统和局部相互作用的调节。与宿主细胞不同,微生物在环境干扰后会发生适应性变化,从而影响宿主-微生物的相互作用。在肝脏中,肠道及其相关微生物群的双向关系创造了一个相互依存的环境。因此,肠道微生物群及其代谢物直接和间接地调节肝脏基因表达,导致肠道-肝脏轴失衡,从而可能导致疾病,包括癌症的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fa2/9232941/dfb598ce7cb4/nihms-1795059-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fa2/9232941/512a0c5d800f/nihms-1795059-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fa2/9232941/c1d25665ccdc/nihms-1795059-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fa2/9232941/dfb598ce7cb4/nihms-1795059-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fa2/9232941/512a0c5d800f/nihms-1795059-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fa2/9232941/c1d25665ccdc/nihms-1795059-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fa2/9232941/dfb598ce7cb4/nihms-1795059-f0003.jpg

相似文献

1
The gut-liver axis: host microbiota interactions shape hepatocarcinogenesis.肠-肝轴:宿主微生物群相互作用塑造肝癌发生。
Trends Cancer. 2022 Jul;8(7):583-597. doi: 10.1016/j.trecan.2022.02.009. Epub 2022 Mar 21.
2
Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancer.肠道微生物群介导的肠-肝轴:理解和治疗肝癌的突破点。
Clin Mol Hepatol. 2025 Apr;31(2):350-381. doi: 10.3350/cmh.2024.0857. Epub 2024 Dec 11.
3
Gut microbiota influence tumor development and Alter interactions with the human immune system.肠道微生物群影响肿瘤的发展,并改变与人类免疫系统的相互作用。
J Exp Clin Cancer Res. 2021 Jan 25;40(1):42. doi: 10.1186/s13046-021-01845-6.
4
Host-Microbiome Interaction in Lung Cancer.肺癌中的宿主-微生物组相互作用。
Front Immunol. 2021 May 24;12:679829. doi: 10.3389/fimmu.2021.679829. eCollection 2021.
5
The role of immune cells in the liver tumor microenvironment: an involvement of gut microbiota-derived factors.免疫细胞在肝脏肿瘤微环境中的作用:肠道微生物群衍生因子的参与
Int Immunol. 2022 Sep 6;34(9):467-474. doi: 10.1093/intimm/dxac020.
6
The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases.肠-肝轴在免疫重塑中的作用:肝脏疾病的新见解。
Int J Biol Sci. 2020 Jun 23;16(13):2357-2366. doi: 10.7150/ijbs.46405. eCollection 2020.
7
The Interplay between Gut Microbiota and the Immune System in Liver Transplant Recipients and Its Role in Infections.肝移植受者肠道微生物群与免疫系统的相互作用及其在感染中的作用。
Infect Immun. 2021 Oct 15;89(11):e0037621. doi: 10.1128/IAI.00376-21. Epub 2021 Aug 30.
8
Short-chain fatty acids reverses gut microbiota dysbiosis-promoted progression of glioblastoma by up-regulating M1 polarization in the tumor microenvironment.短链脂肪酸通过上调肿瘤微环境中 M1 极化逆转肠道菌群失调促进胶质母细胞瘤的进展。
Int Immunopharmacol. 2024 Nov 15;141:112881. doi: 10.1016/j.intimp.2024.112881. Epub 2024 Aug 18.
9
The gut-liver axis in immune remodeling of hepatic cirrhosis.肠-肝轴在肝硬化免疫重塑中的作用。
Front Immunol. 2022 Aug 8;13:946628. doi: 10.3389/fimmu.2022.946628. eCollection 2022.
10
The gut-liver axis in liver disease: Pathophysiological basis for therapy.肝脏疾病中的肠-肝轴:治疗的病理生理学基础。
J Hepatol. 2020 Mar;72(3):558-577. doi: 10.1016/j.jhep.2019.10.003. Epub 2019 Oct 14.

引用本文的文献

1
Regulatory Mechanisms of Phenolic Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review.代谢功能障碍相关脂肪性肝病中酚酸的调节机制:综述
Antioxidants (Basel). 2025 Jun 20;14(7):760. doi: 10.3390/antiox14070760.
2
The tumor microbiome in cancer progression: mechanisms and therapeutic potential.癌症进展中的肿瘤微生物群:机制与治疗潜力
Mol Cancer. 2025 Jul 15;24(1):195. doi: 10.1186/s12943-025-02403-w.
3
Interaction Between Periodontitis and MASLD: Pathophysiological Associations and Possibilities of Prevention and Therapy.

本文引用的文献

1
Functional role of the cancer microbiome in the solid tumour niche.癌症微生物群在实体瘤微环境中的功能作用。
Curr Res Immunol. 2021 Jan 19;2:1-6. doi: 10.1016/j.crimmu.2021.01.001. eCollection 2021.
2
Maternal regulation of biliary disease in neonates via gut microbial metabolites.母源调控新生儿胆汁淤积症:肠道微生物代谢产物的作用
Nat Commun. 2022 Jan 10;13(1):18. doi: 10.1038/s41467-021-27689-4.
3
Hepatic stellate cell activation and senescence induced by intrahepatic microbiota disturbances drive progression of liver cirrhosis toward hepatocellular carcinoma.
牙周炎与代谢相关脂肪性肝病(MASLD)之间的相互作用:病理生理关联以及预防和治疗的可能性
Biomedicines. 2025 May 30;13(6):1346. doi: 10.3390/biomedicines13061346.
4
Chronic Inflammation and Immune Dysregulation in Metabolic-Dysfunction-Associated Steatotic Liver Disease Progression: From Steatosis to Hepatocellular Carcinoma.代谢功能障碍相关脂肪性肝病进展中的慢性炎症与免疫失调:从脂肪变性到肝细胞癌
Biomedicines. 2025 May 21;13(5):1260. doi: 10.3390/biomedicines13051260.
5
Intestinal Microbiome Modulation of Therapeutic Efficacy of Cancer Immunotherapy.肠道微生物群对癌症免疫治疗疗效的调节作用
Gastroenterol Clin North Am. 2025 Jun;54(2):295-315. doi: 10.1016/j.gtc.2024.10.005. Epub 2025 Jan 24.
6
Editorial: Innovative multidisciplinary insights into the gut-liver axis and cancer.社论:关于肠-肝轴与癌症的创新性多学科见解
Front Oncol. 2025 Apr 22;15:1588708. doi: 10.3389/fonc.2025.1588708. eCollection 2025.
7
Modulation of gut microbiota in targeted cancer therapy: insights on the EGFR/VEGF/KRAS pathways.靶向癌症治疗中肠道微生物群的调节:对表皮生长因子受体/血管内皮生长因子/ Kirsten 大鼠肉瘤病毒癌基因同源物途径的见解
Cancer Biol Med. 2024 Nov 25;21(12):1141-55. doi: 10.20892/j.issn.2095-3941.2024.0320.
8
Integrated global and unique metabolic characteristics to reveal the intervention effect of Yiyi decoction on acute pancreatitis.综合全局和独特代谢特征揭示依依汤对急性胰腺炎的干预作用。
PLoS One. 2024 Nov 21;19(11):e0310689. doi: 10.1371/journal.pone.0310689. eCollection 2024.
9
Modulation of liver metabolism and gut microbiota by Alhagi-honey alleviated heat stress-induced liver damage.骆驼刺蜂蜜对肝脏代谢和肠道微生物群的调节减轻了热应激诱导的肝损伤。
Stress Biol. 2024 Sep 30;4(1):41. doi: 10.1007/s44154-024-00178-6.
10
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma.用于肝细胞癌诊断和治疗选择的生物标志物。
Mol Cancer. 2024 Sep 6;23(1):189. doi: 10.1186/s12943-024-02101-z.
肝内微生物失调诱导的肝星状细胞激活和衰老促使肝硬化向肝细胞癌进展。
J Immunother Cancer. 2022 Jan;10(1). doi: 10.1136/jitc-2021-003069.
4
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.膳食纤维和益生菌会影响肠道微生物组和黑色素瘤免疫治疗反应。
Science. 2021 Dec 24;374(6575):1632-1640. doi: 10.1126/science.aaz7015. Epub 2021 Dec 23.
5
A Predictive Model Based on the Gut Microbiota Improves the Diagnostic Effect in Patients With Cholangiocarcinoma.基于肠道微生物组的预测模型可提高胆管癌患者的诊断效果。
Front Cell Infect Microbiol. 2021 Nov 23;11:751795. doi: 10.3389/fcimb.2021.751795. eCollection 2021.
6
Microbiome and cancer.微生物群与癌症
Cancer Cell. 2021 Oct 11;39(10):1317-1341. doi: 10.1016/j.ccell.2021.08.006. Epub 2021 Sep 9.
7
Commensal inter-bacterial interactions shaping the microbiota.共生细菌间相互作用塑造微生物群。
Curr Opin Microbiol. 2021 Oct;63:158-171. doi: 10.1016/j.mib.2021.07.011. Epub 2021 Aug 5.
8
The immunological and metabolic landscape in primary and metastatic liver cancer.原发性和转移性肝癌的免疫和代谢景观。
Nat Rev Cancer. 2021 Sep;21(9):541-557. doi: 10.1038/s41568-021-00383-9. Epub 2021 Jul 29.
9
Gut-microbiota-targeted diets modulate human immune status.靶向肠道微生物组的饮食可调节人体免疫状态。
Cell. 2021 Aug 5;184(16):4137-4153.e14. doi: 10.1016/j.cell.2021.06.019. Epub 2021 Jul 12.
10
Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel.通过口服菊粉凝胶原位调节肠道微生物组来产生全身性抗肿瘤免疫。
Nat Biomed Eng. 2021 Nov;5(11):1377-1388. doi: 10.1038/s41551-021-00749-2. Epub 2021 Jun 24.